Clinical trial
Mithramycin for Lung, Esophagus, and Other Chest Cancers
NCT01624090
Study timeline
Study start (actual)2012-09-06Date precision: day
Registry last updated2019-12-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Esophageal Cancerunresolved
Mesotheliomaunresolved
Gastrointestinal Neoplasmsunresolved
Breast Cancerunresolved
Interventions
MithramycinDRUG
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01624090 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.